- cafead   Oct 04, 2022 at 10:52: AM
via Ocugen has secured exclusive regional rights to an intranasally delivered COVID-19 vaccine, positioning it to advance an intervention that already has emergency authorization in India toward the market in other parts of the world.
article source
article source